BackNurix Therapeutics Overview

Nurix Therapeutics Other Current Assets

Nurix Therapeutics's other current assets is $13M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$12.95M
22.78% YoYΔ $2.40M vs prior year quarter

Peer average

Loading

Nurix Therapeutics Other Current Assets History

Loading

Nurix Therapeutics vs. peers: Other Current Assets Comparison

Loading

Nurix Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nurix Therapeutics (NRIX) FAQ

As of the most recent data (May 2026), NRIX shows a other current assets of $13M. That compares with $11M in the prior-year period — up 22.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRIX's other current assets is now $13M (was $11M) — a 22.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Nurix Therapeutics is outperforming or lagging.

Tracking NRIX's other current assets over time shows whether Nurix Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $13M That compares with $11M in the prior-year period — up 22.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Nurix Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $13M) with ownership activity and broader fundamentals.

Nurix Therapeutics's other current assets is $13M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.